Central-boost Ablative Radiation Therapy for Solid Tumors (CBART)

Recruiting now · Phase 2

Conditions studied: Pancreatic Cancer

In brief

In the case of large tumors or tumors closely adjacent to organs at risk, ablative doses offered by stereotactic body radiation therapy (SBRT) could not be delivered. Therefore, a technique that could provide high radiation doses to tumors without increasing of risks of severe adverse effects is required.

Key facts

Study ID
NCT06427460
Run by
Changhai Hospital
People needed
67
Starts
2024-05-12
Expected to finish
2026-12-31
Last updated by the study team
2024-05-23

Who can join

Age: 18 and older, up to 75. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

You may not qualify if…

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.